Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1991 1
1997 1
2003 1
2005 1
2006 1
2007 1
2008 3
2009 1
2010 3
2011 1
2012 2
2013 2
2014 6
2015 3
2016 5
2017 7
2018 8
2019 3
2020 4
2021 6
2022 9
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Point-of-care lung ultrasound for the assessment of pneumonia: a narrative review in the COVID-19 era.
Kameda T, Mizuma Y, Taniguchi H, Fujita M, Taniguchi N. Kameda T, et al. J Med Ultrason (2001). 2021 Jan;48(1):31-43. doi: 10.1007/s10396-020-01074-y. Epub 2021 Jan 13. J Med Ultrason (2001). 2021. PMID: 33438132 Free PMC article. Review.
In the coronavirus disease-2019 (COVID-19) era, point-of-care lung ultrasound (LUS) has attracted increased attention. ...The knowledge and ideas on the application of LUS in the management of pneumonia that are expected to accumulate in the COVID-19 era may provide …
In the coronavirus disease-2019 (COVID-19) era, point-of-care lung ultrasound (LUS) has attracted increased attention. ...The knowled …
Practice guidance for stress echocardiography.
Hirano Y, Amano M, Obokata M, Izumo M, Utsunomiya H. Hirano Y, et al. J Echocardiogr. 2024 Mar;22(1):1-15. doi: 10.1007/s12574-024-00643-1. Epub 2024 Feb 15. J Echocardiogr. 2024. PMID: 38358595 Review.
At that time, stress echocardiography was not yet widely disseminated in Japan; therefore, the 2018 practical guidance for the implementation of stress echocardiography included a report on stress echocardiography and a specific protocol to promote its use at many institutions in …
At that time, stress echocardiography was not yet widely disseminated in Japan; therefore, the 2018 practical guidance for the implementatio …
Current status of vaccine immunotherapy for gastrointestinal cancers.
Suzuki N, Shindo Y, Nakajima M, Tsunedomi R, Nagano H. Suzuki N, et al. Surg Today. 2023 Dec 3. doi: 10.1007/s00595-023-02773-y. Online ahead of print. Surg Today. 2023. PMID: 38043066 Review.
Recent advances in tumor immunology and molecular drug development have ushered in a new era of cancer immunotherapy. Immunotherapy has shown promising results for several types of tumors, such as advanced melanoma, non-small cell lung cancer, renal cell carcinoma, bladder …
Recent advances in tumor immunology and molecular drug development have ushered in a new era of cancer immunotherapy. Immunotherapy h …
Preoperative evaluation and indications for pulmonary metastasectomy.
Kanzaki R, Fukui E, Kanou T, Ose N, Funaki S, Minami M, Shintani Y, Okumura M. Kanzaki R, et al. J Thorac Dis. 2021 Apr;13(4):2590-2602. doi: 10.21037/jtd-19-3791. J Thorac Dis. 2021. PMID: 34012607 Free PMC article. Review.
Pulmonary metastasectomy (PM) is an established treatment that can provide improved long-term survival for patients with metastatic tumor(s) in the lung. In the current era, where treatment options other than PM such as stereotactic body radiation therapy (SBRT), immunothe …
Pulmonary metastasectomy (PM) is an established treatment that can provide improved long-term survival for patients with metastatic tumor(s) …
Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
Miyamoto K, Minami Y. Miyamoto K, et al. Int J Mol Sci. 2020 Jul 20;21(14):5114. doi: 10.3390/ijms21145114. Int J Mol Sci. 2020. PMID: 32698349 Free PMC article. Review.
Some of these mutations are actionable mutations that affect the response to an approved targeted treatment that is available for off-label treatment or that is available in clinical trials. The era of precision medicine for AML has arrived, and it is extremely important t …
Some of these mutations are actionable mutations that affect the response to an approved targeted treatment that is available for off-label …
National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study.
Kurogi R, Kada A, Ogasawara K, Nishimura K, Kitazono T, Iwama T, Matsumaru Y, Sakai N, Shiokawa Y, Miyachi S, Kuroda S, Shimizu H, Yoshimura S, Osato T, Horie N, Nagata I, Nozaki K, Date I, Hashimoto Y, Hoshino H, Nakase H, Kataoka H, Ohta T, Fukuda H, Tamiya N, Kurogi AI, Ren N, Nishimura A, Arimura K, Shimogawa T, Yoshimoto K, Onozuka D, Ogata S, Hagihara A, Saito N, Arai H, Miyamoto S, Tominaga T, Iihara K; J-ASPECT Study Collaborators. Kurogi R, et al. BMJ Open. 2023 Apr 10;13(4):e068642. doi: 10.1136/bmjopen-2022-068642. BMJ Open. 2023. PMID: 37037619 Free PMC article.
Additional studies are necessary to determine the effect of confounders such as aneurysm complexity on outcomes of clipped patients in the modern endovascular era....
Additional studies are necessary to determine the effect of confounders such as aneurysm complexity on outcomes of clipped patients in the m …
Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date.
Akamine T, Toyokawa G, Tagawa T, Seto T. Akamine T, et al. Onco Targets Ther. 2018 Aug 22;11:5093-5101. doi: 10.2147/OTT.S165511. eCollection 2018. Onco Targets Ther. 2018. PMID: 30174447 Free PMC article. Review.
The identification of anaplastic lymphoma kinase (ALK), an oncogenetic driver mutation, in lung cancer has paved the way for a new era in the treatment of non-small cell lung cancer (NSCLC). Targeting ALK using tyrosine kinase inhibitors (TKI) has dramatically improved the …
The identification of anaplastic lymphoma kinase (ALK), an oncogenetic driver mutation, in lung cancer has paved the way for a new era …
71 results